Abstract: A method and a network for routing data packet in a unified wide area network (WAN) is provided. The method includes encapsulating a data packet by an ingress aggregation router and forwarding the encapsulated data packet to an ingress backbone router. The encapsulated data packet includes a first label. The ingress backbone router selects an optimized traffic engineered tunnel and replaces the first label with the optimized traffic engineered tunnel and forwards the encapsulated data packet along the optimized traffic engineered tunnel.

Abstract: Method and apparatus are disclosed for collective electronic commerce and distribution of items, such as fungible items/goods and non-fungible items/goods. A system manages a universal ecommerce shopping cart to facilitate creating an itinerary for a group across multiple vendor websites/applications. The systems manages inventory to interface with multiple vendors, manages groups, and/or manages the assignment of fungible items (e.g., products) and non-fungible items (e.g., tickets, access to hotel rooms, etc.) that were selected for being purchased at different times.

Abstract: The systems, devices, and methods described herein include an inventive user interface including a combination of linear and non-linear data content access. The user interface may display a first portion a content map including content objects and digital content associated with said content objects, receive a user input, and communicate with a processor. In response to the user input and/or processor instructions, the user interface may display a second portion of the content map with associated content objects and digital content. The systems described herein may comprise a memory configured to store the content map and/or digital content and a communications module configured to communicate with at least one content server via a data network. The processor may be arranged to control operations of the memory, communications module, and user interface, and instruct the user interface to display portions of the content map and digital content.

Abstract: The present invention provides a therapeutic compound of formula (I) and their pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of HIV infection or combination therapy of HIV-1 protease inhibitors (PIs) and/or reverse transcriptase inhibitors (nRTIs) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in HIV patient.

Abstract: The present invention provides a therapeutic compound of formula (I) and their pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of HIV infection or combination therapy of HIV-1 protease inhibitors (Pis) and/or reverse transcriptase inhibitors (nRTIs) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in HIV patient.

Abstract: The present invention provides a therapeutic compound of formula (I) and their pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of HIV infection or combination therapy of HIV-1 protease inhibitors (PIs) and/or reverse transcriptase inhibitors (nRTIs) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in HIV patient.

Abstract: The present invention provides a therapeutic compound of formula (I) and their pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of HIV infection or combination therapy of HIV-1 protease inhibitors (PIs) and/or reverse transcriptase inhibitors (nRTIs) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in HIV patient.

Abstract: The present invention provides a therapeutic compound of formula (I) and their pharmaceutically acceptable salts for the prevention and treatment of lipodystrophy caused because of HIV infection or combination therapy of HIV-1 protease inhibitors (Pis) and/or reverse transcriptase inhibitors (nRTIs) by neutralizing lipohypertrophy, lipoatrophy and metabolic abnormalities in HIV patient.